Purchase #7: Mayne Pharma Group Ltd
I’ve made another purchase for the 10foot portfolio, generic pharmaceutical company Mayne Pharma Group Ltd (ASX: MYX). Mayne manufactures and sells generics, consults for third parties, sells its own specialty branded drugs, and develops new formulations for existing molecules. Mayne Pharma recently had a huge step-change in its operations after the $900m acquisition of a portfolio …
The things that move share prices
I have recently been reading through well-known investing blogs like Bronte Capital (John Hempton) and Bristlemouth (Forager/Steve Johnson) from their beginnings in 2008 or so. They are very good. I read Hempton’s in its entirety a few years ago and I would recommend his earlier posts as an excellent crash course in how the truck …
The Gig Economy
Despite being financially comfortable and gainfully employed myself, one of the things I find myself becoming increasingly opposed to is the growing ‘gig-ification’ of work and/or what I see as the increasing abuse of workers (which are sometimes the same thing and sometimes two separate issues). So much has been said about this in the …
Sell #2: Sold Thorn Group Ltd
I’ve sold my stake in Thorn Group Ltd (ASX: TGA). Upon careful reflection, which I hinted at recently , I’ve lost confidence in my investment in the company. It’s not so much that things have changed, more that I think I was framing the investment the wrong way when I bought. I have also tied together …
Scuttlebutt – August 2017 edition
I’m a big believer in the usefulness of scuttlebutt for investing. I think you typically can’t rely on it as it is all anecdotal, but you can use it to check that progress is happening, or to check that you’re thinking about your investment in the right way. Here are a few tidbits I’ve noted …
Purchase #6: NGE Capital Ltd
Recently I made the 6th purchase for the 10foot portfolio, a small LIC known as NGE Capital Ltd (ASX: NGE), formerly New Guinea Energy. It’s ultra-concentrated, with a market capitalisation of $18 million, and lead by an experienced manager with a solid track record. I’ve never owned an LIC of this style before, so I’m breaking …
Sell #1: Sold RNY
This is a story about a shrewd property investor who paid 3.3 cents per share for properties worth 12 cents per share and then sold said shares for 0.9 cents. I sold RNY Property Trust (ASX: RNY) at $0.09 per share on Friday 21/07, realising $124.55 after brokerage, for a loss of $410.90, or 76.4%. The …
The first broken thesis: RNY Property Trust
Hokey dokey, so, today ticked off two dubious ‘first-evers’ in investing for me: First time I held a company that fell 70% in a day. First time I held a company that fell 70%. Not the kind of boxes you want to be ticking. RNY Property Trust (ASX: RNY) went tits up, slipped, and fell off …
Quarterly review: Q4 2017
3 months since my first purchase, it’s time for a review of the quarter ended 30 June 2017. I have called it Q4 in reflection of the fact that it is the final quarter of FY17, although it is in fact the first quarter of my portfolio experiment. There’s really not a lot to report …
One that didn’t cut the mustard
A quick comment on one company I have liked for a while but repeatedly elected not to invest in; Rent.com.au Ltd (ASX: RNT). Its premise is that it is a scalable online advertising platform that a) attracts a unique audience and its products have great cost-benefit ratio for landlords, and b) with rentconnect, online renter CV …
